Pharmaceutical groups are increasingly relying on real-world data (RWD) to accelerate drug development and optimize clinical trial design. Despite this, accessing, analyzing, and interpreting complex RWD can challenging. Datma's Federated Biomarker Explorer provides a innovative solution by providin